Solpadeine

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Solpadeine is the brand name of pain-relief medication containing paracetamol, caffeine and codeine currently made by Omega Pharma.[1] Before Over-the-counter drug portfolio acquisition by Omega Pharma in 2012 it was made by GlaxoSmithKline.[2]

In the United Kingdom there are four different medicines using the Solpadeine name, with no common active ingredient between them.

The range includes:

  • Solpadeine Headache, a combination of paracetamol and caffeine
  • Solpadeine Plus, a compound analgesic containing paracetamol and codeine (Co-codamol), with caffeine
  • Solpadeine Max, a compound analgesic containing paracetamol and codeine (Co-codamol), with a higher codeine content than Solpadeine Plus
  • Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine

Solpadeine Max tablets contain 12.8 mg of codeine, which in combination with the paracetamol, is effective at relieving mild to moderate pain.

In Australia it is marketed as Panadeine.[3]

External links[edit]

References[edit]

  1. ^ "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 2013-09-14. 
  2. ^ Corporate Comms (2012-03-15). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 2013-09-14. 
  3. ^ "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 2008-11-17. Retrieved 2013-09-14.